| Basics |
| Company: |
Gyre Therapeutics, Inc. |
| IPO Date: |
August 21, 2015 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.02B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.29 | 3.82%
|
| Avg Daily Range (30 D): |
$0.50 | 4.42%
|
| Avg Daily Range (90 D): |
$0.43 | 3.47%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.43M |
| Avg Daily Volume (30 D): |
.11M |
| Avg Daily Volume (90 D): |
.07M |
| Trade Size |
| Avg Trade Size (Sh.): |
264 |
| Avg Trade Size (Sh.) (30 D): |
61 |
| Avg Trade Size (Sh.) (90 D): |
58 |
| Institutional Trades |
| Total Inst.Trades: |
110 |
| Avg Inst. Trade: |
$1.6M |
| Avg Inst. Trade (30 D): |
$3.18M |
| Avg Inst. Trade (90 D): |
$3.18M |
| Avg Inst. Trade Volume: |
.49M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.05M |
| Avg Closing Trade (30 D): |
$3.18M |
| Avg Closing Trade (90 D): |
$3.18M |
| Avg Closing Volume: |
668.23K |
|
|
|
|
| News |
Jun 18, 2024 @ 8:05 PM
Gyre Therapeutics Announces Publication in Journal...
Source: Gyre Therapeutics, Inc.
|
May 28, 2024 @ 8:05 PM
Gyre Therapeutics Announces Expected Addition to t...
Source: Gyre Therapeutics, Inc.
|
May 9, 2024 @ 8:10 PM
Gyre Therapeutics Reports First Quarter 2024 Finan...
Source: Gyre Therapeutics, Inc.
|
Apr 11, 2024 @ 5:33 PM
Why Fastenal Shares Are Trading Lower By Around 7%...
Source: Avi Kapoor
|
Apr 11, 2024 @ 2:01 PM
Enliven Therapeutics, Alpine Immune Sciences, Janu...
Source: Avi Kapoor
|
| Financials |
| |
TTM |
Q2 2024 |
Q1 2024 |
|
Basic EPS
|
$.01
|
$.04
|
$.09
|
|
Diluted EPS
|
$.01
|
$.01
|
$.03
|
|
Revenue
|
$ 25.49M
|
$ 25.23M
|
$ 27.17M
|
|
Gross Profit
|
$ 24.53M
|
$ 24.46M
|
$ 26.19M
|
|
Net Income / Loss
|
$ 4.59M
|
$ 4.54M
|
$ 9.94M
|
|
Operating Income / Loss
|
$ 4.23M
|
$ 3.26M
|
$ 8.07M
|
|
Cost of Revenue
|
$ .96M
|
$ .77M
|
$ .98M
|
|
Net Cash Flow
|
$ -.34M
|
$ -13.61M
|
$ -3.68M
|
|
PE Ratio
|
1,119.00
|
|
|
| Splits |
| Jan 13, 2023:
1:2
|
| Feb 13, 2017:
15:1
|
| Aug 21, 2015:
7:1
|
|
